Wilson Disease — Research Summary
Printed from RareWays (rareways.com.au) on 26 July 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Risk Factors for Postoperative Complications After Splenectomy in Wilson's Disease: A 986-Patient Single-Center Cohort Study.
Shi Xiuquan et al. — Journal of investigative surgery : the official journal of the Academy of Surgical Research (1 December 2026)
https://pubmed.ncbi.nlm.nih.gov/41657263/
- 2.
Injectable Cu
Zhu Jianwei et al. — Biomaterials (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/41911651/
- 3.
Late Adult-Onset Wilson Disease in ATP7B p.Met665Ile Variant: Further Evidence for Reduced Penetrance and a Hypomorphic Effect.
Niesert Moritz et al. — American journal of medical genetics. Part A (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41931015/
- 4.
Mechanistic study on GANDouling tablet in the treatment of Wilson's disease with cognitive impairment based on network pharmacology and transcriptomic analysis.
Hu Xia et al. — Tissue & cell (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41793790/
- 5.
APASL clinical practice guidance: the diagnosis and management of patients with Wilson's disease.
Zhang Wei et al. — Hepatology international (1 July 2026)
https://pubmed.ncbi.nlm.nih.gov/42387232/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Wilson Disease
Wilson disease is a genetic condition where copper accumulates in the liver, brain, and other organs due to a faulty ATP7B gene. If untreated it causes liver failure and neurological problems. Early detection and lifelong copper-chelation therapy can prevent serious complications and allow a near-normal life.
Most Recent Research
INTRODUCTION: Splenectomy is commonly performed in Wilson's disease patients with hypersplenism secondary to portal hypertension, yet large-scale data on postoperative complications remain scarce. METHODS: A retrospective analysis was conducted on 986 Wilson's disease patients who underwent splenectomy between 2001 and 2019. RESULTS: The overall postoperative complication rate was 68.7%, with bleeding, fever, and portal vein thrombosis occurring in 29.0%, 44.9%, and 20.5% of cases, respectively. Multivariable analysis identified hypersplenism grade as an independent risk factor for postoperative bleeding, abnormal liver function for postoperative fever, and lower alanine aminotransferase and albumin levels for portal vein thrombosis. DISCUSSION: These findings suggest that preoperative evaluation of hypersplenism severity, liver function, and key laboratory markers can aid in surgical risk stratification and optimize perioperative management for Wilson's disease patients undergoing splenectomy.
Common Questions
What is Wilson Disease?
Wilson disease is a genetic condition where copper accumulates in the liver, brain, and other organs due to a faulty ATP7B gene. If untreated it causes liver failure and neurological problems. Early detection and lifelong copper-chelation therapy can prevent serious complications and allow a near-normal life.
How many clinical trials are available for Wilson Disease?
RareWays currently indexes 62 clinical trials for Wilson Disease, of which 16 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Wilson Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Wilson Disease.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.